Intercure Ltd. (NASDAQ: INCR)

Intercure Ltd., a company listed on the Nasdaq Global Market and the Tel Aviv Stock Exchange under the symbols INCR and INCRF, operates in the pharmaceutical industry, specifically as a leading producer and distributor of pharmaceutical-grade cannabis and cannabis-based products for medical use. Established in 1994, Intercure has been at the forefront of the cannabis industry for over 16 years.

Intercure's main business activities involve the production, manufacturing, exporting, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use. The company's products are manufactured using processes that meet the highest standards required by regulators, including Good Manufacturing Practice (GMP) standards. Intercure's products are distributed through a network of pharmacies and stores across Israel, the UK, and Austria. The company has also established partnerships with leading companies in the industry to expand its global footprint.

The company generates revenue through the sale of pharmaceutical-grade cannabis, cannabis-based products, and CBD products. These products are designed to meet the needs of patients with various medical conditions, including chronic pain, nausea, and sleep disorders. Intercure's rigorous protocols for cultivation, harvest, and processing ensure consistency, quality, and efficiency.

Intercure holds a competitive advantage in the industry through its experience and expertise in producing pharmaceutical-grade cannabis, its established distribution network, and its partnerships with leading companies in the industry. The company's focus on quality and efficiency sets it apart from its competitors.

Intercure's customers include pharmacies and patients in Israel, the UK, and Austria, as well as pharmaceutical distributors in Germany and the UK. The company's products are used in clinical trials to study the efficacy and safety of cannabis-based treatments, and Intercure has established partnerships with leading research institutions to advance the development of cannabis-based treatments.

Intercure's brand names and/or trade names of its products and services include pharmaceutical-grade cannabis, cannabis-based products, and CBD products. The company's focus on quality and efficiency is reflected in its branding, as it strives to meet the needs of patients with various medical conditions.